Global Opioids Drug Market Growth 2020-2025
According to this study, over the next five years the Opioids Drug market will register a -1.9%% CAGR in terms of revenue, the global market size will reach $ 9473.1 million by 2025, from $ 10210 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Opioids Drug business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Opioids Drug market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Opioids Drug, covering the supply chain analysis, impact assessment to the Opioids Drug market size growth rate in several scenarios, and the measures to be undertaken by Opioids Drug companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Oxycodone
Hydromorphone
Codeine
Fentanyl
Other
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Pain Relief
Anesthesia
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Teva
Mylan
Purdue Pharma
Amneal Pharma
Collegium
Mallinckrodt
Pfizer
J&J
INSYS
Endo
Hikma
Egalet
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Opioids Drug consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Opioids Drug market by identifying its various subsegments.
Focuses on the key global Opioids Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Opioids Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Opioids Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Opioids Drug Consumption 2015-2025
2.1.2 Opioids Drug Consumption CAGR by Region
2.2 Opioids Drug Segment by Type
2.2.1 Oxycodone
2.2.2 Hydromorphone
2.2.3 Codeine
2.2.4 Fentanyl
2.2.5 Other
2.3 Opioids Drug Consumption by Type
2.3.1 Global Opioids Drug Consumption Market Share by Type (2015-2020)
2.3.2 Global Opioids Drug Revenue and Market Share by Type (2015-2020)
2.3.3 Global Opioids Drug Sale Price by Type (2015-2020)
2.4 Opioids Drug Segment by Application
2.4.1 Pain Relief
2.4.2 Anesthesia
2.4.3 Other
2.5 Opioids Drug Consumption by Application
2.5.1 Global Opioids Drug Consumption Market Share by Type (2015-2020)
2.5.2 Global Opioids Drug Value and Market Share by Type (2015-2020)
2.5.3 Global Opioids Drug Sale Price by Type (2015-2020)
3 Global Opioids Drug by Company
3.1 Global Opioids Drug Sales Market Share by Company
3.1.1 Global Opioids Drug Sales by Company (2018-2020)
3.1.2 Global Opioids Drug Sales Market Share by Company (2018-2020)
3.2 Global Opioids Drug Revenue Market Share by Company
3.2.1 Global Opioids Drug Revenue by Company (2018-2020)
3.2.2 Global Opioids Drug Revenue Market Share by Company (2018-2020)
3.3 Global Opioids Drug Sale Price by Company
3.4 Global Opioids Drug Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Opioids Drug Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Opioids Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Opioids Drug by Regions
4.1 Opioids Drug by Regions
4.2 Americas Opioids Drug Consumption Growth
4.3 APAC Opioids Drug Consumption Growth
4.4 Europe Opioids Drug Consumption Growth
4.5 Middle East & Africa Opioids Drug Consumption Growth
5 Americas
5.1 Americas Opioids Drug Consumption by Countries
5.1.1 Americas Opioids Drug Consumption by Countries (2015-2020)
5.1.2 Americas Opioids Drug Value by Countries (2015-2020)
5.2 Americas Opioids Drug Consumption by Type
5.3 Americas Opioids Drug Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Opioids Drug Consumption by Regions
6.1.1 APAC Opioids Drug Consumption by Regions (2015-2020)
6.1.2 APAC Opioids Drug Value by Regions (2015-2020)
6.2 APAC Opioids Drug Consumption by Type
6.3 APAC Opioids Drug Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Opioids Drug by Countries
7.1.1 Europe Opioids Drug Consumption by Countries (2015-2020)
7.1.2 Europe Opioids Drug Value by Countries (2015-2020)
7.2 Europe Opioids Drug Consumption by Type
7.3 Europe Opioids Drug Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Opioids Drug by Countries
8.1.1 Middle East & Africa Opioids Drug Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Opioids Drug Value by Countries (2015-2020)
8.2 Middle East & Africa Opioids Drug Consumption by Type
8.3 Middle East & Africa Opioids Drug Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Opioids Drug Distributors
10.3 Opioids Drug Customer
11 Global Opioids Drug Market Forecast
11.1 Global Opioids Drug Consumption Forecast (2021-2025)
11.2 Global Opioids Drug Forecast by Regions
11.2.1 Global Opioids Drug Forecast by Regions (2021-2025)
11.2.2 Global Opioids Drug Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Opioids Drug Forecast by Type
11.8 Global Opioids Drug Forecast by Application
12 Key Players Analysis
12.1 Teva
12.1.1 Company Information
12.1.2 Opioids Drug Product Offered
12.1.3 Teva Opioids Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Teva Latest Developments
12.2 Mylan
12.2.1 Company Information
12.2.2 Opioids Drug Product Offered
12.2.3 Mylan Opioids Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Mylan Latest Developments
12.3 Purdue Pharma
12.3.1 Company Information
12.3.2 Opioids Drug Product Offered
12.3.3 Purdue Pharma Opioids Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Purdue Pharma Latest Developments
12.4 Amneal Pharma
12.4.1 Company Information
12.4.2 Opioids Drug Product Offered
12.4.3 Amneal Pharma Opioids Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Amneal Pharma Latest Developments
12.5 Collegium
12.5.1 Company Information
12.5.2 Opioids Drug Product Offered
12.5.3 Collegium Opioids Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Collegium Latest Developments
12.6 Mallinckrodt
12.6.1 Company Information
12.6.2 Opioids Drug Product Offered
12.6.3 Mallinckrodt Opioids Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Mallinckrodt Latest Developments
12.7 Pfizer
12.7.1 Company Information
12.7.2 Opioids Drug Product Offered
12.7.3 Pfizer Opioids Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Pfizer Latest Developments
12.8 J&J
12.8.1 Company Information
12.8.2 Opioids Drug Product Offered
12.8.3 J&J Opioids Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 J&J Latest Developments
12.9 INSYS
12.9.1 Company Information
12.9.2 Opioids Drug Product Offered
12.9.3 INSYS Opioids Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 INSYS Latest Developments
12.10 Endo
12.10.1 Company Information
12.10.2 Opioids Drug Product Offered
12.10.3 Endo Opioids Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Endo Latest Developments
12.11 Hikma
12.11.1 Company Information
12.11.2 Opioids Drug Product Offered
12.11.3 Hikma Opioids Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Hikma Latest Developments
12.12 Egalet
12.12.1 Company Information
12.12.2 Opioids Drug Product Offered
12.12.3 Egalet Opioids Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Egalet Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Opioids Drug Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Oxycodone
Table 5. Major Players of Hydromorphone
Table 6. Major Players of Codeine
Table 7. Major Players of Fentanyl
Table 8. Major Players of Other
Table 9. Global Consumption Sales by Type (2015-2020)
Table 10. Global Opioids Drug Consumption Market Share by Type (2015-2020)
Table 11. Global Opioids Drug Revenue by Type (2015-2020) ($ million)
Table 12. Global Opioids Drug Value Market Share by Type (2015-2020) ($ Millions)
Table 13. Global Opioids Drug Sale Price by Type (2015-2020)
Table 14. Global Consumption Sales by Application (2015-2020)
Table 15. Global Opioids Drug Consumption Market Share by Application (2015-2020)
Table 16. Global Opioids Drug Value by Application (2015-2020)
Table 17. Global Opioids Drug Value Market Share by Application (2015-2020)
Table 18. Global Opioids Drug Sale Price by Application (2015-2020)
Table 19. Global Opioids Drug Sales by Company (2017-2019) (M Units)
Table 20. Global Opioids Drug Sales Market Share by Company (2017-2019)
Table 21. Global Opioids Drug Revenue by Company (2017-2019) ($ Millions)
Table 22. Global Opioids Drug Revenue Market Share by Company (2017-2019)
Table 23. Global Opioids Drug Sale Price by Company (2017-2019)
Table 24. Global Opioids Drug Manufacturing Base Distribution and Sales Area by Manufacturers
Table 25. Players Opioids Drug Products Offered
Table 26. Opioids Drug Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 27. Global Opioids Drug Consumption by Regions 2015-2020 (M Units)
Table 28. Global Opioids Drug Consumption Market Share by Regions 2015-2020
Table 29. Global Opioids Drug Value by Regions 2015-2020 ($ Millions)
Table 30. Global Opioids Drug Value Market Share by Regions 2015-2020
Table 31. Americas Opioids Drug Consumption by Countries (2015-2020) (M Units)
Table 32. Americas Opioids Drug Consumption Market Share by Countries (2015-2020)
Table 33. Americas Opioids Drug Value by Countries (2015-2020) ($ Millions)
Table 34. Americas Opioids Drug Value Market Share by Countries (2015-2020)
Table 35. Americas Opioids Drug Consumption by Type (2015-2020) (M Units)
Table 36. Americas Opioids Drug Consumption Market Share by Type (2015-2020)
Table 37. Americas Opioids Drug Consumption by Application (2015-2020) (M Units)
Table 38. Americas Opioids Drug Consumption Market Share by Application (2015-2020)
Table 39. APAC Opioids Drug Consumption by Countries (2015-2020) (M Units)
Table 40. APAC Opioids Drug Consumption Market Share by Countries (2015-2020)
Table 41. APAC Opioids Drug Value by Regions (2015-2020) ($ Millions)
Table 42. APAC Opioids Drug Value Market Share by Regions (2015-2020)
Table 43. APAC Opioids Drug Consumption by Type (2015-2020) (M Units)
Table 44. APAC Opioids Drug Consumption Market Share by Type (2015-2020)
Table 45. APAC Opioids Drug Consumption by Application (2015-2020) (M Units)
Table 46. APAC Opioids Drug Consumption Market Share by Application (2015-2020)
Table 47. Europe Opioids Drug Consumption by Countries (2015-2020) (M Units)
Table 48. Europe Opioids Drug Consumption Market Share by Countries (2015-2020)
Table 49. Europe Opioids Drug Value by Countries (2015-2020) ($ Millions)
Table 50. Europe Opioids Drug Value Market Share by Countries (2015-2020)
Table 51. Europe Opioids Drug Consumption by Type (2015-2020) (M Units)
Table 52. Europe Opioids Drug Consumption Market Share by Type (2015-2020)
Table 53. Europe Opioids Drug Consumption by Application (2015-2020) (M Units)
Table 54. Europe Opioids Drug Consumption Market Share by Application (2015-2020)
Table 55. Middle East & Africa Opioids Drug Consumption by Countries (2015-2020) (M Units)
Table 56. Middle East & Africa Opioids Drug Consumption Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Opioids Drug Value by Countries (2015-2020) ($ Millions)
Table 58. Middle East & Africa Opioids Drug Value Market Share by Countries (2015-2020)
Table 59. Middle East & Africa Opioids Drug Consumption by Type (2015-2020) (M Units)
Table 60. Middle East & Africa Opioids Drug Consumption Market Share by Type (2015-2020)
Table 61. Middle East & Africa Opioids Drug Consumption by Application (2015-2020) (M Units)
Table 62. Middle East & Africa Opioids Drug Consumption Market Share by Application (2015-2020)
Table 63. Opioids Drug Distributors List
Table 64. Opioids Drug Customer List
Table 65. Global Opioids Drug Consumption Forecast by Countries (2021-2025) (M Units)
Table 66. Global Opioids Drug Consumption Market Forecast by Regions
Table 67. Global Opioids Drug Value Forecast by Countries (2021-2025) ($ Millions)
Table 68. Global Opioids Drug Value Market Share Forecast by Regions
Table 69. Global Opioids Drug Consumption Forecast by Type (2021-2025) (M Units)
Table 70. Global Opioids Drug Consumption Market Share Forecast by Type (2021-2025)
Table 71. Global Opioids Drug Value Forecast by Type (2021-2025) ($ Millions)
Table 72. Global Opioids Drug Value Market Share Forecast by Type (2021-2025)
Table 73. Global Opioids Drug Consumption Forecast by Application (2021-2025) (M Units)
Table 74. Global Opioids Drug Consumption Market Share Forecast by Application (2021-2025)
Table 75. Global Opioids Drug Value Forecast by Application (2021-2025) ($ Millions)
Table 76. Global Opioids Drug Value Market Share Forecast by Application (2021-2025)
Table 77. Teva Product Offered
Table 78. Teva Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 79. Teva Main Business
Table 80. Teva Latest Developments
Table 81. Teva Basic Information, Company Total Revenue (in $ million), Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 82. Mylan Product Offered
Table 83. Mylan Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 84. Mylan Main Business
Table 85. Mylan Latest Developments
Table 86. Mylan Basic Information, Company Total Revenue (in $ million), Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 87. Purdue Pharma Product Offered
Table 88. Purdue Pharma Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 89. Purdue Pharma Main Business
Table 90. Purdue Pharma Latest Developments
Table 91. Purdue Pharma Basic Information, Company Total Revenue (in $ million), Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 92. Amneal Pharma Product Offered
Table 93. Amneal Pharma Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 94. Amneal Pharma Main Business
Table 95. Amneal Pharma Latest Developments
Table 96. Amneal Pharma Basic Information, Company Total Revenue (in $ million), Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 97. Collegium Product Offered
Table 98. Collegium Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 99. Collegium Main Business
Table 100. Collegium Latest Developments
Table 101. Collegium Basic Information, Company Total Revenue (in $ million), Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 102. Mallinckrodt Product Offered
Table 103. Mallinckrodt Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 104. Mallinckrodt Main Business
Table 105. Mallinckrodt Latest Developments
Table 106. Mallinckrodt Basic Information, Company Total Revenue (in $ million), Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 107. Pfizer Product Offered
Table 108. Pfizer Basic Information, Company Total Revenue (in $ million), Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 109. Pfizer Main Business
Table 110. Pfizer Latest Developments
Table 111. Pfizer Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 112. J&J Product Offered
Table 113. J&J Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 114. J&J Main Business
Table 115. J&J Latest Developments
Table 116. J&J Basic Information, Company Total Revenue (in $ million), Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 117. INSYS Product Offered
Table 118. INSYS Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 119. INSYS Main Business
Table 120. INSYS Latest Developments
Table 121. INSYS Basic Information, Company Total Revenue (in $ million), Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 122. Endo Product Offered
Table 123. Endo Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 124. Endo Main Business
Table 125. Endo Latest Developments
Table 126. Endo Basic Information, Company Total Revenue (in $ million), Opioids Drug Manufacturing Base, Sales Area and Its Competitors
Table 127. Hikma Product Offered
Table 128. Hikma Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 129. Hikma Main Business
Table 130. Hikma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 131. Hikma Latest Developments
Table 132. Egalet Product Offered
Table 133. Egalet Opioids Drug Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 134. Egalet Main Business
Table 135. Egalet Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 136. Egalet Latest Developments
List of Figures
Figure 1. Picture of Opioids Drug
Figure 2. Opioids Drug Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Opioids Drug Consumption Growth Rate 2015-2025 (M Units)
Figure 5. Global Opioids Drug Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Oxycodone
Figure 7. Product Picture of Hydromorphone
Figure 8. Product Picture of Codeine
Figure 9. Product Picture of Fentanyl
Figure 10. Product Picture of Other
Figure 11. Global Opioids Drug Consumption Market Share by Type (2015-2020)
Figure 12. Global Opioids Drug Value Market Share by Type (2015-2020)
Figure 13. Opioids Drug Consumed in Pain Relief
Figure 14. Global Opioids Drug Market: Pain Relief (2015-2020) (M Units)
Figure 15. Global Opioids Drug Market: Pain Relief (2015-2020) ($ Millions)
Figure 16. Opioids Drug Consumed in Anesthesia
Figure 17. Global Opioids Drug Market: Anesthesia (2015-2020) (M Units)
Figure 18. Global Opioids Drug Market: Anesthesia (2015-2020) ($ Millions)
Figure 19. Opioids Drug Consumed in Other
Figure 20. Global Opioids Drug Market: Other (2015-2020) (M Units)
Figure 21. Global Opioids Drug Market: Other (2015-2020) ($ Millions)
Figure 22. Global Opioids Drug Consumption Market Share by Application (2015-2020)
Figure 23. Global Opioids Drug Value Market Share by Application (2015-2020)
Figure 24. Global Opioids Drug Sales Market Share by Company in 2017
Figure 25. Global Opioids Drug Sales Market Share by Company in 2019
Figure 26. Global Opioids Drug Revenue Market Share by Company in 2017
Figure 27. Global Opioids Drug Revenue Market Share by Company in 2019
Figure 28. Global Opioids Drug Sale Price by Company in 2019
Figure 29. Global Opioids Drug Consumption Market Share by Regions 2015-2020
Figure 30. Global Opioids Drug Value Market Share by Regions 2015-2020
Figure 31. Americas Opioids Drug Consumption 2015-2020 (M Units)
Figure 32. Americas Opioids Drug Value 2015-2020 ($ Millions)
Figure 33. APAC Opioids Drug Consumption 2015-2020 (M Units)
Figure 34. APAC Opioids Drug Value 2015-2020 ($ Millions)
Figure 35. Europe Opioids Drug Consumption 2015-2020 (M Units)
Figure 36. Europe Opioids Drug Value 2015-2020 ($ Millions)
Figure 37. Middle East & Africa Opioids Drug Consumption 2015-2020 (M Units)
Figure 38. Middle East & Africa Opioids Drug Value 2015-2020 ($ Millions)
Figure 39. Americas Opioids Drug Consumption Market Share by Countries in 2019
Figure 40. Americas Opioids Drug Value Market Share by Countries in 2019
Figure 41. Americas Opioids Drug Consumption Market Share by Type in 2019
Figure 42. Americas Opioids Drug Consumption Market Share by Application in 2019
Figure 43. United States Opioids Drug Consumption Growth 2015-2020 (M Units)
Figure 44. United States Opioids Drug Value Growth 2015-2020 ($ Millions)
Figure 45. Canada Opioids Drug Consumption Growth 2015-2020 (M Units)
Figure 46. Canada Opioids Drug Value Growth 2015-2020 ($ Millions)
Figure 47. Mexico Opioids Drug Consumption Growth 2015-2020 (M Units)
Figure 48. Mexico Opioids Drug Value Growth 2015-2020 ($ Millions)
Figure 49. APAC Opioids Drug Consumption Market Share by Countries in 2019
Figure 50. APAC Opioids Drug Value Market Share by Regions in 2019
Figure 51. APAC Opioids Drug Consumption Market Share by Type in 2019
Figure 52. APAC Opioids Drug Consumption Market Share by Application in 2019
Figure 53. China Opioids Drug Consumption Growth 2015-2020 (M Units)
Figure 54. China Opioids Drug Value Growth 2015-2020 ($ Millions)
Figure 55. Japan Opioids Drug Consumption Growth 2015-2020 (M Units)
Figure 56. Japan Opioids Drug Value Growth 2015-2020 ($ Millions)
Figure 57. Korea Opioids Drug Consumption Growth 2015-2020 (M Units)
Figure 58. Korea Opioids Drug Value Growth 2015-2020 ($ Millions)
Figure 59. Southeast Asia Opioids Drug Consumption Growth 2015-2020 (M Units)
Figure 60. Southeast Asia Opioids Drug Value Growth 2015-2020 ($ Millions)
Figure 61. India Opioids Drug Consumption Growth 2015-2020 (M Units)
Figure 62. India Opioids Drug Value Growth 2015-2020 ($ Millions)
Figure 63. Australia Opioids Drug Consumption Growth 2015-2020 (M Units)
Figure 64. Australia Opioids Drug Value Growth 2015-2020 ($ Millions)
Figure 65. Europe Opioids Drug Consumption Market Share by Countries in 2019
Figure 66. Europe Opioids Drug Value Market Share by Countries in 2019
Figure 67. Europe Opioids Drug Consumption Market Share by Type in 2019
Figure 68. Europe Opioids Drug Consumption Market Share by Application in 2019
Figure 69. Germany Opioids Drug Consumption Growth 2015-2020 (M Units)
Figure 70. Germany Opioids Drug Value Growth 2015-2020 ($ Millions)
Figure 71. France Opioids Drug Consumption Growth 2015-2020 (M Units)
Figure 72. France Opioids Drug Value Growth 2015-2020 ($ Millions)
Figure 73. UK Opioids Drug Consumption Growth 2015-2020 (M Units)
Figure 74. UK Opioids Drug Value Growth 2015-2020 ($ Millions)
Figure 75. Italy Opioids Drug Consumption Growth 2015-2020 (M Units)
Figure 76. Italy Opioids Drug Value Growth 2015-2020 ($ Millions)
Figure 77. Russia Opioids Drug Consumption Growth 2015-2020 (M Units)
Figure 78. Russia Opioids Drug Value Growth 2015-2020 ($ Millions)
Figure 79. Middle East & Africa Opioids Drug Consumption Market Share by Countries in 2019
Figure 80. Middle East & Africa Opioids Drug Value Market Share by Countries in 2019
Figure 81. Middle East & Africa Opioids Drug Consumption Market Share by Type in 2019
Figure 82. Middle East & Africa Opioids Drug Consumption Market Share by Application in 2019
Figure 83. Egypt Opioids Drug Consumption Growth 2015-2020 (M Units)
Figure 84. Egypt Opioids Drug Value Growth 2015-2020 ($ Millions)
Figure 85. South Africa Opioids Drug Consumption Growth 2015-2020 (M Units)
Figure 86. South Africa Opioids Drug Value Growth 2015-2020 ($ Millions)
Figure 87. Israel Opioids Drug Consumption Growth 2015-2020 (M Units)
Figure 88. Israel Opioids Drug Value Growth 2015-2020 ($ Millions)
Figure 89. Turkey Opioids Drug Consumption Growth 2015-2020 (M Units)
Figure 90. Turkey Opioids Drug Value Growth 2015-2020 ($ Millions)
Figure 91. GCC Countries Opioids Drug Consumption Growth 2015-2020 (M Units)
Figure 92. GCC Countries Opioids Drug Value Growth 2015-2020 ($ Millions)
Figure 93. Global Opioids Drug Consumption Growth Rate Forecast (2021-2025) (M Units)
Figure 94. Global Opioids Drug Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 95. Americas Opioids Drug Consumption 2021-2025 (M Units)
Figure 96. Americas Opioids Drug Value 2021-2025 ($ Millions)
Figure 97. APAC Opioids Drug Consumption 2021-2025 (M Units)
Figure 98. APAC Opioids Drug Value 2021-2025 ($ Millions)
Figure 99. Europe Opioids Drug Consumption 2021-2025 (M Units)
Figure 100. Europe Opioids Drug Value 2021-2025 ($ Millions)
Figure 101. Middle East & Africa Opioids Drug Consumption 2021-2025 (M Units)
Figure 102. Middle East & Africa Opioids Drug Value 2021-2025 ($ Millions)
Figure 103. United States Opioids Drug Consumption 2021-2025 (M Units)
Figure 104. United States Opioids Drug Value 2021-2025 ($ Millions)
Figure 105. Canada Opioids Drug Consumption 2021-2025 (M Units)
Figure 106. Canada Opioids Drug Value 2021-2025 ($ Millions)
Figure 107. Mexico Opioids Drug Consumption 2021-2025 (M Units)
Figure 108. Mexico Opioids Drug Value 2021-2025 ($ Millions)
Figure 109. Brazil Opioids Drug Consumption 2021-2025 (M Units)
Figure 110. Brazil Opioids Drug Value 2021-2025 ($ Millions)
Figure 111. China Opioids Drug Consumption 2021-2025 (M Units)
Figure 112. China Opioids Drug Value 2021-2025 ($ Millions)
Figure 113. Japan Opioids Drug Consumption 2021-2025 (M Units)
Figure 114. Japan Opioids Drug Value 2021-2025 ($ Millions)
Figure 115. Korea Opioids Drug Consumption 2021-2025 (M Units)
Figure 116. Korea Opioids Drug Value 2021-2025 ($ Millions)
Figure 117. Southeast Asia Opioids Drug Consumption 2021-2025 (M Units)
Figure 118. Southeast Asia Opioids Drug Value 2021-2025 ($ Millions)
Figure 119. India Opioids Drug Consumption 2021-2025 (M Units)
Figure 120. India Opioids Drug Value 2021-2025 ($ Millions)
Figure 121. Australia Opioids Drug Consumption 2021-2025 (M Units)
Figure 122. Australia Opioids Drug Value 2021-2025 ($ Millions)
Figure 123. Germany Opioids Drug Consumption 2021-2025 (M Units)
Figure 124. Germany Opioids Drug Value 2021-2025 ($ Millions)
Figure 125. France Opioids Drug Consumption 2021-2025 (M Units)
Figure 126. France Opioids Drug Value 2021-2025 ($ Millions)
Figure 127. UK Opioids Drug Consumption 2021-2025 (M Units)
Figure 128. UK Opioids Drug Value 2021-2025 ($ Millions)
Figure 129. Italy Opioids Drug Consumption 2021-2025 (M Units)
Figure 130. Italy Opioids Drug Value 2021-2025 ($ Millions)
Figure 131. Russia Opioids Drug Consumption 2021-2025 (M Units)
Figure 132. Russia Opioids Drug Value 2021-2025 ($ Millions)
Figure 133. Spain Opioids Drug Consumption 2021-2025 (M Units)
Figure 134. Spain Opioids Drug Value 2021-2025 ($ Millions)
Figure 135. Egypt Opioids Drug Consumption 2021-2025 (M Units)
Figure 136. Egypt Opioids Drug Value 2021-2025 ($ Millions)
Figure 137. South Africa Opioids Drug Consumption 2021-2025 (M Units)
Figure 138. South Africa Opioids Drug Value 2021-2025 ($ Millions)
Figure 139. Israel Opioids Drug Consumption 2021-2025 (M Units)
Figure 140. Israel Opioids Drug Value 2021-2025 ($ Millions)
Figure 141. Turkey Opioids Drug Consumption 2021-2025 (M Units)
Figure 142. Turkey Opioids Drug Value 2021-2025 ($ Millions)
Figure 143. GCC Countries Opioids Drug Consumption 2021-2025 (M Units)
Figure 144. GCC Countries Opioids Drug Value 2021-2025 ($ Millions)
Figure 145. Teva Opioids Drug Market Share (2018-2020)
Figure 146. Mylan Opioids Drug Market Share (2018-2020)
Figure 147. Purdue Pharma Opioids Drug Market Share (2018-2020)
Figure 148. Amneal Pharma Opioids Drug Market Share (2018-2020)
Figure 149. Collegium Opioids Drug Market Share (2018-2020)
Figure 150. Mallinckrodt Opioids Drug Market Share (2018-2020)
Figure 151. Pfizer Opioids Drug Market Share (2018-2020)
Figure 152. J&J Opioids Drug Market Share (2018-2020)
Figure 153. INSYS Opioids Drug Market Share (2018-2020)
Figure 154. Endo Opioids Drug Market Share (2018-2020)
Figure 155. Hikma Opioids Drug Market Share (2018-2020)
Figure 156. Egalet Opioids Drug Market Share (2018-2020)
